Document:

Amendment No. 3 to Manufacturing Services Agreement

 Exhibit 10.1 
 AMENDMENT NO. 3 TO MANUFACTURING SERVICES AGREEMENT 
 This Amendment No. 3 to
Manufacturing Services Agreement (this “Amendment”) is made as of September 12, 2012 (the “Effective Date”) and amends certain portions the Manufacturing Services Agreement (the “Agreement”), dated as of
February 1, 2006 and amended as of June 19, 2008 and October 1, 2008, by and between Somaxon Pharmaceuticals, Inc. (“Somaxon”) and Patheon Pharmaceuticals Inc. (“Patheon”). 

RECITALS 

A. The Agreement sets forth certain rights and obligations of each of the parties relating to supply of Products to Somaxon by Patheon;
and 
 B. The parties now desire to amend the Agreement as set forth herein. 

NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein and for good and valuable consideration, the
receipt and adequacy of which are hereby acknowledged, the parties hereby agree as follows: 
 1. Construction.
Capitalized terms used and not defined herein shall have the meanings assigned to such terms in the Agreement. 
 2.
Amendment to Agreement. 
 (a) The first paragraph of Section 2.1 of the Agreement shall be amended and restated to
read in its entirety as follows: 
 “During the term of this Agreement, Patheon shall manufacture and supply, in accordance
with the provisions of this Agreement, all quantities of the Products ordered by the Client consistent with Article 5, and shall provide such Manufacturing Services for the Territory for the fees specified in Schedules C and D. The Client shall
purchase at least (i) 75% of its requirement of Products of between 0 – 80 million tablets per Year; and (ii) 50% of its requirement of Products of greater than 80 million tablets per Year, for sale in the Territory from
Patheon pursuant to the terms of this Agreement; provided, however, that such requirement shall expire on July 31, 2013, with the Year 2013 for this purpose being deemed to run from January 1, 2013 through July 31, 2013. In providing
the Manufacturing Services, the Client and Patheon agree that:” 
 (b) Section 10.2(c) of the Agreement is deleted in
its entirety and replaced with the following: 
 “(c) Maximum Liability: Except as set forth in Sections 10.2(a) and
10.3, and excluding Patheon’s liability for replacement Product under Article 6, Patheon’s maximum liability under this Agreement for any reason whatsoever, shall not exceed in a Year, in the aggregate, 20% of the purchase price for
Product arising from Firm Orders submitted in such Year up to a cap of $300,000.” 

 (c) Schedule E (ACTIVE MATERIALS & ACTIVE MATERIALS SUPPLIER) of the
Agreement is deleted in its entirety and is replaced with the attached Revised Schedule E. 
 3. Effect of Amendment;
Conflicts. Except as expressly amended by this Amendment, the Agreement shall continue in full force and effect. If there is any conflict between the terms of the Agreement and the terms of this Amendment, the terms of this Amendment shall
govern and control. 
 4. Further Assurances. The parties agree to execute such further instruments, agreements and
documents and to take such further actions as may reasonably be necessary to carry out the intent of this Amendment. 
 5.
Counterparts. This Amendment may be executed in any number of counterparts, each which shall be deemed an original, and all of which together shall constitute one instrument. 

6. Entire Agreement. This Amendment, together with the Agreement and the documents referenced herein and therein, constitute the
full and entire understanding and agreement among the parties with regard to the subjects hereof and thereof. 
 IN WITNESS
WHEREOF, the parties have executed this Amendment as of the date first above written. 
  

			
	SOMAXON PHARMACEUTICALS, INC.
		
	By:	 	/s/ Brian T. Dorsey
		
	Name:	 	Brian T. Dorsey
		
	Title:	 	SVP, Regulatory Affairs and
		 	Technical Operations
	
	PATHEON PHARMACEUTICALS INC.
		
	By:	 	/s/ Francis P. McCune
		
	Name:	 	Francis P. McCune
		
	Title:	 	Secretary

 REVISED SCHEDULE E (Amendment 3 to MSA) 

ACTIVE MATERIALS & ACTIVE MATERIALS SUPPLIER 

 

					
	 Active Material
	  	 Supplier
	  	 Active Materials Reimbursement Value

	Doxepin HCl	  	Teva Pharmaceutical Industries. Ltd or its
affiliate·	  	The lesser of the current actual cost per kg. of Active Materials from the Supplier or $400 per kg., up to a maximum aggregate amount per Year of 10% of the purchase price for
Product arising from Firm Orders submitted during the Year up to a cap of $100,000 per Year. If at any time the actual cost of Active Materials exceeds $400 per kg., the parties will reasonably agree on a new per kg. value to reflect the actual cost
of Active Materials and a new maximum aggregate amount per Year.Amendment to Employment Agreement

 Exhibit 10.1 
 Amendment to Employment Agreement 
 Dated September 10, 2012 between Realogy
Corporation (the “Company”) 
 and Richard A. Smith (the “Executive”). 

WHEREAS, the Company and the Executive are parties to that certain Employment Agreement, dated as of April 10, 2007; and 

WHEREAS, the Company and Executive desire to amend that Employment Agreement with an extension to the Employment Period (as defined in
the Employment Agreement). 
 NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follow: 
  

	1.	Section 1 of the Employment Agreement is hereby amended to change the end of the Initial Term of the Agreement from the “fifth anniversary of the Effective
Date” to “April 9, 2016”. 

  

	2.	Except as otherwise provided in this Amendment, the Employment Agreement shall remain in full force and effect. 

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first above written. 

 

			
	REALOGY CORPORATION
		
	By:	 	 /s/ David J. Weaving

		 	 Name: David J. Weaving
 Title:
EVP/Chief Administrative Officer

  

	
	/s/ Richard A. Smith
	Richard A. SmithWaiver of Registration Rights

 Exhibit 4.7 
 WAIVER OF REGISTRATION RIGHTS 
 This Waiver of Registration Rights is
entered into as of September 14, 2012 by and between Nanosphere, Inc., a Delaware corporation (the “Company”), and the undersigned holders of shares of capital stock of the Company (the “Stockholders”).

 WHEREAS, the Company is contemplating filing with the Securities and Exchange Commission a universal shelf registration
statement on Form S-3 (the “Registration Statement”) covering the primary offering of securities by the Company; 
 WHEREAS, pursuant to Section 2 of the Second Amended and Restated Registration Rights Agreement dated as of August 19, 2009 (the “Agreement”) by and between the Company and
certain of its stockholders, the Company has granted certain registration rights with respect to Registrable Securities (as such term is defined in the Agreement) beneficially owned by the Stockholders in connection with the registration of
securities by the Company under the Securities Act of 1933, as amended; 
 WHEREAS, the undersigned Stockholders represent
holders of at least fifty-one percent (51%) of the outstanding shares of the Company’s common stock issued upon conversion of the Company’s series C-2 preferred stock that are Registrable Securities (as such term is defined in the
Agreement) and are the only holders of shares of the Company’s common stock that are Registrable Securities as of the date hereof (as such term is defined in the Agreement); and 

WHEREAS, the undersigned Stockholders desire to waive their registration rights and any and all notice requirements in order to preserve
for the Company maximum flexibility in meeting the Company’s financial and other needs in connection with offerings that may be undertaken by the Company under the Registration Statement. 

NOW, THEREFORE, upon the execution of this Waiver of Registration Rights by the Company and the undersigned Stockholders, and pursuant to
Sections 2(a) and 11(d) of the Agreement, the undersigned Stockholders hereby waive the registration rights and any and all notice requirements of the Stockholders under the Agreement in connection with the Registration Statement. 

This Waiver of Registration Rights shall be binding on the undersigned and the successors, heirs, personal representatives and assigns of
the undersigned. 
 [SIGNATURE PAGE FOLLOWS] 

 IN WITNESS WHEREOF, the parties have executed this Waiver of Registration Rights effective
as of the date first above written. 
  

			
	NANOSPHERE, INC.
		
	By:	 	/s/ William P. Moffitt, III
		 	 William P. Moffitt, III

Chief Executive Officer

  

			
	AOQ TRUST
		
	By:	 	/s/ Mark Slezak
		 	 Mark Slezak
 Authorized
Signatory

  

			
	LFT PARTNERSHIP
		
	By:	 	/s/ Mark Slezak
		 	 Mark Slezak
 Authorized
Signatory

  

			
	ALFA-TECH, LLC
		
	By:	 	/s/ Mark Slezak
		 	 Mark Slezak
 Authorized
Signatory

  

			
	LURIE INVESTMENT FUND, L.L.C.
		
	By:	 	/s/ Mark Slezak
		 	 Mark Slezak
 Authorized
Signatory

  

			
	LURIE INVESTMENTS, INC.
		
	By:	 	/s/ Mark Slezak
		 	 Mark Slezak
 Authorized
Signatory

  

			
	EAGLE CAPITAL MANAGEMENT, LLC
		
	By:	 	/s/ Mark Slezak
		 	 Mark Slezak
 Authorized
Signatory

 [SIGNATURE PAGE TO WAIVER OF REGISTRATION RIGHTS] 

 
			
	WASK INVESTMENTS, L.L.C.
		
	By:	 	/s/ Mark Slezak
		 	 Mark Slezak
 Authorized
Signatory

  

			
	ANN AND ROBERT H. LURIE FOUNDATION
		
	By:	 	/s/ Mark Slezak
		 	 Mark Slezak
 Authorized
Signatory

		
		 	/s/ William P. Moffitt, III
		 	William P. Moffitt, III

  

			
		
		 	/s/ Mark Slezak
		 	Mark Slezak

  

			
		
		 	/s/ Chad Mirkin
		 	Chad A. Mirkin

 [SIGNATURE PAGE TO WAIVER OF REGISTRATION RIGHTS]EX-10.2

 Exhibit 10.2 
 Execution Version 
 AMENDMENT NO. 1 TO CREDIT AGREEMENT 

AMENDMENT NO. 1 TO CREDIT AGREEMENT, dated as of July 17, 2012 (this “Amendment”), is entered into by and among
Zayo Group, LLC, a Delaware limited liability company (“Zayo Group”), Zayo Capital, Inc., a Delaware corporation (“Zayo Capital”; and together with Zayo Group, the “Borrowers”), Morgan Stanley
Senior Funding, Inc., as term facility administrative agent (the “Term Facility Administrative Agent”), SunTrust Bank, as revolving facility administrative agent (the “Revolving Facility Administrative Agent” and,
together with the Term Facility Administrative Agent, the “Administrative Agents”) and the undersigned lenders (the “Lenders”). 
 PRELIMINARY STATEMENTS: 
 WHEREAS, the Borrowers, certain subsidiaries
thereof, the Administrative Agents and the Lenders entered into that certain Credit Agreement, dated as of July 2, 2012 (the “Credit Agreement”; capitalized terms not otherwise defined in this Amendment have the same meanings
as specified in the Credit Agreement). 
 WHEREAS, the Borrowers, the undersigned Lenders and the Administrative Agents have
agreed to amend the Credit Agreement as hereinafter set forth; 
 NOW, THEREFORE, in consideration of the premises and for other
good and valuable consideration (the receipt and sufficiency of which are hereby acknowledged), the parties hereto hereby agree as follows: 
 SECTION 1. Amendments to Credit Agreement. The Credit Agreement is, effective as of the date hereof and subject to the satisfaction of the conditions precedent set forth in Section 3, hereby
amended as follows: 
 (a) Section 1.1 of the Credit Agreement is hereby amended by restating the definition of the term
“Bank Products” as follows: 
 “Bank Products” shall mean any of the following services provided to
any Borrower Party by any Person who at the time such services are extended (or entered into, in the case of Lender Hedge Agreements) is a Lender (or any Affiliate of a Lender): (a) any treasury or other cash management services, including
deposit accounts, automated clearing house (ACH) origination and other funds transfer, depository (including cash vault and check deposit), zero balance accounts and sweeps, return items processing, controlled disbursement accounts, positive pay,
lockboxes and lockbox accounts, account reconciliation and information reporting, payables outsourcing, payroll processing, trade finance services, investment accounts and securities accounts, (b) card services, including credit cards
(including purchasing cards and commercial cards), prepaid cards, including payroll, stored value and gift cards, merchant services processing, and debit card services and (c) Lender Hedge Agreements. 

Amendment No. 1 to 
 Credit Agreement 

 (b) Section 1.1 of the Credit Agreement is hereby amended by restating the definition
of the term “Lender Group” as follows: 
 “Lender Group” shall mean, collectively, the Administrative
Agents, the Issuing Bank, the Lenders and, solely where such term is used in reference to the guarantees, the security interests and the Collateral in each case pursuant to the Loan Documents (including, without limitation, (a) the definitions
of the terms “Collateral”, “Permitted Liens” and “Secured Parties” in Section 1.1 of this Agreement, (b) Sections 3.1 and 10.15 of this Agreement and (c) the Security Agreement), any party to a Bank
Product Document other than any Borrower Party. 
 (c) Section 2.11(a) of the Credit Agreement is hereby amended in its
entirety to read as follows: 
 Payments Prior to Event of Default. At all times during which an Event of Default has not
occurred and is continuing, all amounts received by any Administrative Agent from the Borrowers, shall be distributed by such Administrative Agent in the following order of priority: 

FIRST, pro rata, to the payment of (i) out-of-pocket costs and expenses (including reasonable attorneys’ fees) of each
Administrative Agent and the Collateral Agent incurred by such Administrative Agent and the Collateral Agent in connection with the enforcement of the rights of the Lender Group under the Loan Documents pursuant to either Facility and (ii) any
Agent Advances made by the Revolving Facility Administrative Agent under or pursuant to the terms of the Loan Documents and interest accrued thereon; 
 SECOND, pro rata, to the payment of any fees and reimbursable expenses then due and payable to each Administrative Agent, the Issuing Bank or the Swing Line Bank hereunder or under any other Loan
Documents; 
 THIRD, pro rata, to the payment of all Obligations consisting of accrued fees and interest then due and payable to
the Lenders hereunder; 
 FOURTH, to the payment of principal then due and payable on the Loans and unreimbursed Letter of
Credit Obligations (or cash collateral up to 105% of outstanding exposure) and to the payment of the Obligations arising in respect of Bank Products then due and payable, on a pro rata basis; 

FIFTH, to the payment of all other Obligations not otherwise referred to in this Section 2.11(a) then due and payable; and

 SIXTH, upon satisfaction in full of all Obligations, to the Borrowers or as otherwise required by law. 

(d) Section 2.11(b) of the Credit Agreement is hereby amended in its entirety to read as follows: 

Payments Subsequent to Event of Default. Notwithstanding anything in this Agreement or any other Loan Document which may be
construed to the contrary, subsequent to the occurrence and during the continuance of an Event of Default, payments and prepayments with respect to the Obligations made to the Lender Group, or any of them, or otherwise received by any member of the
Lender Group (from realization on Collateral or otherwise) shall be distributed in the following order of priority (subject, as applicable, to Section 2.10 and to the terms and provisions of the Intercreditor Agreement): 

  

					
		  	2	  	 Amendment No. 1 to
 Credit Agreement

 FIRST, pro rata, to the payment of (i) out-of-pocket costs and expenses (including
reasonable attorneys’ fees) of each Administrative Agent and the Collateral Agent incurred in connection with the enforcement of the rights of the Lender Group under the Loan Documents, and (ii) any Agent Advances made by the Revolving
Facility Administrative Agent under or pursuant to the terms of the Loan Documents (including any costs incurred in connection with the sale or disposition of any Collateral); 
 SECOND, pro rata, to payment of any fees owed to each Administrative Agent, the Issuing Bank or the Swing Line Bank hereunder or under any other Loan Document; 

THIRD, to the payment of out-of-pocket costs and expenses (including reasonable attorneys’ fees) of the Lenders incurred in
connection with the enforcement of their respective rights under the Loan Documents; 
 FOURTH, to the payment of all
Obligations consisting of accrued fees and interest payable to the Lenders hereunder; 
 FIFTH, pro rata, to (i) the
payment of principal on the Loans then outstanding, (ii) the Letter of Credit Reserve Account to the extent of one hundred five percent (105%) of any Letter of Credit Obligations then outstanding and (iii) to the payment of any
Obligation arising in respect of the Bank Products; 
 SIXTH, to any other Obligations not otherwise referred to in this
Section 2.11(b); and 
 SEVENTH, upon satisfaction in full of all Obligations, to the Borrowers or as otherwise
required by law. 
 SECTION 2. Reference to and Effect on the Loan Documents. On and after the Effective Date, each
reference in the Credit Agreement to “this Agreement”, “hereunder”, “hereof” or words of like import referring to the Credit Agreement, and each reference in the other Loan Documents to “the Credit Agreement”,
“thereunder”, “thereof” or words of like import referring to the “Credit Agreement”, shall mean and be a reference to the Credit Agreement, as amended by this Amendment. 

(b) The Credit Agreement, as specifically amended by this Amendment, and the other Loan Documents are, and shall continue to be, in full
force and effect, and are hereby in all respects ratified and confirmed. 
 (c) Except as expressly provided herein, the
execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any right, power or remedy of any Lender or the Administrative Agents under the Credit Agreement or any other Loan Document, nor shall it constitute a waiver of
any provision of the Credit Agreement or any Loan Document. 

  

					
		  	3	  	 Amendment No. 1 to
 Credit Agreement

 SECTION 3. Conditions of Effectiveness. This Amendment shall become effective as of
the date (the “Effective Date”) on which the following conditions shall have been satisfied (or waived): 
 (a)
The Administrative Agents shall have received counterparts of this Amendment executed by the Borrowers and the Lenders; and 

(b) After giving effect to this Amendment and the transactions contemplated hereby, the representations and warranties set forth in
Article 5 of the Credit Agreement (as amended by this Amendment) are true and correct in all material respects as of the Effective Date, with the same effect as though made on and as of such date, except to the extent such representations and
warranties expressly relate to an earlier date (in which case such representations and warranties shall be true and correct in all material respects as of such earlier date) and immediately prior to and after giving effect to the Effective Date, no
Default or Event of Default shall have occurred and be continuing. 
 SECTION 4. Representations and Warranties. Each of
the Borrowers hereby represents and warrants to the Administrative Agents that: 
 (a) on and as of the date hereof (i) it
has all requisite corporate or other power and authority to enter into and perform its obligations under this Amendment, the Credit Agreement as amended hereby and the other Loan Documents to which it is a party, and (ii) this Amendment has
been duly authorized, executed and delivered by it; and 
 (b) this Amendment, and the Credit Agreement as amended hereby,
constitute legal, valid and binding obligations of such party, enforceable against it in accordance with their respective terms, subject only to any limitation under Laws relating to (i) bankruptcy, insolvency, reorganization, moratorium or
creditors’ rights generally; and (ii) general equitable principles including the discretion that a court may exercise in the granting of equitable remedies. 
 SECTION 5. Costs and Expenses. The Borrowers agree that all reasonable out-of-pocket expenses incurred by the Administrative Agents in connection with the preparation, execution, delivery and
administration, modification and amendment of this Amendment and the other instruments and documents to be delivered hereunder or in connection herewith (including, without limitation, the reasonable fees, charges and disbursements of counsel for
the Administrative Agents), are expenses that the Borrowers are required to pay or reimburse pursuant to Section 11.2 of the Credit Agreement. 
 SECTION 6. Execution in Counterparts. This Amendment may be executed in one or more counterparts (and by different parties hereto in different counterparts), each of which shall be deemed an
original, but all of which together shall constitute one and the same instrument. Delivery by telecopier or other electronic transmission of an executed counterpart of a signature page to this Amendment shall be effective as delivery of an original
executed counterpart of this Amendment. 
 SECTION 7. GOVERNING LAW. THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED
IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK. 

  

					
		  	4	  	 Amendment No. 1 to
 Credit Agreement

 SECTION 8. WAIVER OF RIGHT OF TRIAL BY JURY. EACH PARTY TO THIS AMENDMENT HEREBY
EXPRESSLY WAIVES ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION ARISING UNDER THIS AMENDMENT, OR IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO OR ANY OF THEM WITH RESPECT TO THE
CREDIT AGREEMENT AS AMENDED HEREBY, OR THE TRANSACTIONS RELATED THERETO, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER FOUNDED IN CONTRACT OR TORT OR OTHERWISE; AND EACH PARTY HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM,
DEMAND, ACTION OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY, AND THAT ANY PARTY TO THIS AGREEMENT MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION 8 WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE SIGNATORIES
HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY. 
 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

  

					
		  	5	  	 Amendment No. 1 to
 Credit Agreement

 IN WITNESS WHEREOF, the parties have caused this Amendment to Credit Agreement to be
executed by their respective authorized officers as of the date first above written. 
  

			
	 ZAYO GROUP, LLC,

as a Borrower
  

	By	 	/s/ Ken desGarennes
		 	 Name: Ken desGarennes
 Title:
Chief Financial Officer

	
	 ZAYO CAPITAL, INC.,

as a Borrower
  

	By:	 	/s/ Ken desGarennes
		 	 Name: Ken desGarennes
 Title:
Chief Financial Officer

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	 MORGAN STANLEY SENIOR FUNDING, INC.,
 as Term Facility Administrative Agent, as a Revolving Facility Lender and a Term Facility Lender

		
	By:	 	/s/ Reagan C. Philipp
		 	Name: Reagan Philipp
		 	Title: Authorized Signatory

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	 SUNTRUST BANK,
 as
Revolving Facility Administrative Agent
 and as a Revolving Facility Lender

		
	By:	 	/s/ Nicholas Hahn
		 	Name:   Nicholas Hahn
		 	Title:     Director

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	 BARCLAYS BANK PLC,

as a Revolving Facility Lender

		
	By:	 	/s/ Gregory Fishbein
		 	Name:  Gregory Fishbein
		 	Title:     Assistant Vice President

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	 ROYAL BANK OF CANADA,
 as a Revolving Facility Lender

		
	By:	 	/s/ Kamran Khan
		 	Name:   Kamran Khan
		 	Title:     Authorized Signatory

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	 GOLDMAN SACHS BANK USA,
 as a Revolving Facility Lender

		
	By:	 	/s/ Robert Ehudin
		 	Name:   Robert Ehudin
		 	Title:     Authorized Signatory

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	 UBS LOAN FINANCE LLC,
 as a Revolving Facility Lender

		
	By:	 	/s/ Irja R. Otsa
		 	Name:   Irja R. Otsa
		 	Title:     Associate Director
		
	By:	 	/s/ Mary E. Evans
		 	Name:   Mary E. Evans
		 	Title:     Associate Director

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

PACIFIC LIFE FUNDS-PL FLOATING RATE INCOME FUND 

By: Pacific Life Fund Advisors LLC 

(dba Pacific Asset Management), in its capacity as Investment Advisor 

as a Term Facility Lender 

 

			
	By:	 	/s/ James P. Leasure
		 	Name:   James P. Leasure
		 	Title:     Senior Managing Director
		
	By:	 	/s/ Dale Hawley
		 	Name:   Dale Hawley
		 	Title:     Assistant Secretary

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	 Luxor Capital Group L.P.
 as a Term Facility Lender

		
	By:	 	 
		 	Name:
		 	Title: Luxor Capital Group, L.P.

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	 Nuveen Floating Rate Income Fund
 By: Symphony Asset Management LLC,
 as a Term Facility Lender

		
	By:	 	 /s/ James Kim

		 	 Name: James Kim
 Title:
  Co-Head of Credit Research

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	 Municipal Employees’ Annuity and Benefit Fund
 of Chicago (Symphony)
 By: Symphony Asset Management LLC,

as a Term Facility Lender

		
	By:	 	 /s/ James Kim

		 	 Name: James Kim
 Title:
  Co-Head of Credit Research

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	 Nuveen Credit Strategies Income Fund
 By: Symphony Asset Management LLC,
 as a Term Facility Lender

		
	By:	 	 /s/ James Kim

		 	 Name: James Kim
 Title:
  Co-Head of Credit Research

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	 Nuveen Symphony Credit Opportunities Fund
 By: Symphony Asset Management LLC,
 as a Term Facility Lender

		
	By:	 	 /s/ James Kim

		 	 Name: James Kim
 Title:
  Co-Head of Credit Research

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	 Nuveen Short Duration Credit Opportunities Fund

By: Symphony Asset Management LLC,

as a Term Facility Lender

		
	 By:
	 	 /s/ James Kim

		 	 Name: James Kim
 Title:
  Co-Head of Credit Research

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	 Nuveen Floating Rate Income Opportunity Fund
 By: Symphony Asset Management LLC,
 as a Term Facility Lender

		
	By:	 	 /s/ James Kim

		 	 Name: James Kim
 Title:
  Co-Head of Credit Research

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	Principal Funds Inc, - Diversified Real Asset Fund
	 By: Symphony Asset Management LLC,
 as a Term Facility Lender

		
	By:	 	 /s/ James Kim

		 	 Name: James Kim
 Title:
  Co-Head of Credit Research

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	 SSF Trust
 By:
Symphony Asset Management LLC,
 as a Term Facility Lender

		
	By:	 	/s/ James Kim
		 	 Name:  James Kim

		 	 Title:    Co-Head of Credit Research

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	 Nuveen Senior Income Fund
 By: Symphony Asset Management LLC,
 as a Term Facility Lender

		
	By:	 	/s/ James Kim
		 	 Name:  James Kim

		 	 Title:    Co-Head of Credit Research

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	 Symphony Credit Opportunities Fund, LTD.
 By: Symphony Asset Management LLC,
 as a Term Facility Lender

		
	By:	 	/s/ James Kim
		 	 Name:  James Kim

		 	 Title:    Co-Head of Credit Research

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	 Symphony CLO II, LTD.
 By: Symphony Asset Management LLC,
 as a Term Facility Lender

		
	By:	 	/s/ James Kim
		 	 Name:  James Kim

		 	 Title:    Co-Head of Credit Research

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	 Symphony CLO IV, LTD.
 By: Symphony Asset Management LLC,
 as a Term Facility Lender

		
	By:	 	/s/ James Kim
		 	 Name:  James Kim

		 	 Title:    Co-Head of Credit Research

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	 Symphony CLO IX, LTD.
 By: Symphony Asset Management LLC,
 as a Term Facility Lender

		
	By:	 	/s/ James Kim
		 	 Name:  James Kim

		 	 Title:    Co-Head of Credit Research

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	 Symphony CLO V, LTD.

By: Symphony Asset Management LLC,
 as a Term
Facility Lender

		
	By:	 	/s/ James Kim
		 	 Name:  James Kim

		 	 Title:    Co-Head of Credit Research

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	 Symphony CLO VII, LTD.
 By: Symphony Asset Management LLC,
 as a Term Facility Lender

		
	By:	 	/s/ James Kim
		 	 Name:  James Kim

		 	 Title:    Co-Head of Credit Research

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	 Symphony CLO VIII, LTD.
 By: Symphony Asset Management LLC,
 as a Term Facility Lender

		
	By:	 	/s/ James Kim
		 	 Name:  James Kim

		 	 Title:    Co-Head of Credit Research

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement 

 
			
	 Symphony Senior Loan Fund, L.P.
 By: Symphony Asset Management LLC,
 as a Term Facility Lender

		
	By:	 	/s/ James Kim
		 	 Name:  James Kim

		 	 Title:    Co-Head of Credit Research

  
 Signature Page
to Amendment No. 1 to 
 Credit Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}]]